JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB126433

Akt (pS473) + total Akt ELISA Kit

3

(1 Review)

|

(21 Publications)

Akt (pS473) + total Akt ELISA Kit is a semi-quantitative sandwich ELISA kit to measure Akt (pS473) and total Akt in cell lysate samples.

- Colorimetric readout - works on any standard plate reader
- Semi quantitative: positive control included
- Measure numerous cell lysates at once

View Alternative Names

PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha

5 Images
Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)
  • sELISA

Supplier Data

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)

A431 cells were treated with recombinant human EGF at 37°C for 20 min. Solubilize cells at 4 x 107 cells/ml in Cell Lysate Buffer. Serial dilutions of lysates were analyzed in this ELISA.

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)
  • sELISA

Supplier Data

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)

NIH3T3 cells were treated or untreated with recombinant human PDGF for 10 min. Cell lysates were analyzed using this phosphoELISA.

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)
  • sELISA

Supplier Data

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)

The NIH3T3 cells were treated with recombinant human PDGF for 10 minutes to induce phosphorylation of Akt. Serial dilutions of lysates were analyzed in this ELISA.

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)
  • sELISA

Unknown

Sandwich ELISA - Akt (pS473) + total Akt ELISA Kit (AB126433)

MCF7 cells were stimulated for five minutes with 1 ug x mL-1 of insulin (ab123768). Cell lysates were assessed for total Akt and Akt(pS473), shown as OD (450 nm) after background signal was subtracted (duplicates +/- SD).

Western blot - Akt (pS473) + total Akt ELISA Kit (AB126433)
  • WB

Supplier Data

Western blot - Akt (pS473) + total Akt ELISA Kit (AB126433)

NIH3T3 cells were treated or untreated with recombinant human PDGF for 10 min. Cell lysates were analyzed by Western Blot.

false

Key facts

Detection method

Colorimetric

Sample types

Cell Lysate

Reacts with

Mouse, Rat, Human

Assay type

Semi-quantitative

Assay time

5h

Assay Platform

Microplate

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

ab126433 is a very rapid, convenient and sensitive assay kit that can monitor the activation or function of important biological pathways in cell lysates. By determining phosphorylated Akt protein in your experimental model system, you can verify pathway activation in your cell lysates. You can simultaneously measure numerous different cell lysates without spending excess time and effort in performing a Western Blot analysis.

This Sandwich ELISA kit is an in vitro enzyme-linked immunosorbent assay for the measurement of phospho-Akt (Ser473) and total Akt in human, mouse and rat cell lysates (help normalize the results of phospho-Akt from different cell lysate being compared). A pan Akt antibody has been coated onto a 96-well plate. Samples are pipetted into the wells and Akt present in a sample is bound to the wells by the immobilized antibody. The wells are washed and anti-phospho-Akt (Ser473) or anti-pan-Akt is used to detect phosphorylated or total Akt. After washing away unbound antibody, HRP-conjugated anti-rabbit IgG is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of Akt (Ser473) or total Akt bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.

Get higher sensitivity in only 90 minutes with AKT 1/2/3 pS473 + AKT1 ELISA Kit (ab176657) from our SimpleStep ELISA® range.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

What's included?

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab126433-1x96Tests", "assetComponentDetails": [ { "size":"1 x 15 mL", "name":"5X Assay Diluent", "number":"AB126433-CMP04", "productcode":"" }, { "size":"1 x 25 mL", "name":"20X Wash Buffer", "number":"AB126433-CMP02", "productcode":"" }, { "size":"1 x 5 mL", "name":"2X Cell Lysis Buffer", "number":"AB126433-CMP07", "productcode":"" }, { "size":"1 x 8 mL", "name":"Stop Solution", "number":"AB126433-CMP05", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Akt Microplate (12 strips x 8 wells) coated with anti-pan Akt antibody", "number":"AB126433-CMP08", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Detection Antibody Akt: rabbit anti-pan-Akt", "number":"AB126433-CMP10", "productcode":"" }, { "size":"1 x 25 µL", "name":"500X HRP-conjugated anti-rabbit IgG", "number":"AB126433-CMP03", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Detection Antibody Akt (Ser473): rabbit anti-phospho-Akt (Ser473)", "number":"AB126433-CMP09", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Positive Control: lyophilized NIH3T3 cell lysate", "number":"AB126433-CMP01", "productcode":"" }, { "size":"1 x 12 mL", "name":"TMB One-Step Substrate Reagent", "number":"AB126433-CMP06", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The AKT family consists of three serine/threonine kinases: AKT1 AKT2 and AKT3 sometimes called protein kinase B (PKB). These kinases play a central role in various cellular processes. They have a mass of approximately 56-60 kDa and are expressed in numerous tissues including skeletal muscle pancreas and brain. AKT functions as an important regulator of cellular metabolism growth proliferation and survival. In their active form AKT proteins get phosphorylated; common phosphorylation targets include AKT ser473 (AKT ps473) which reflects their activation state.
Biological function summary

AKT kinases participate in multiple signaling cascades that control cell survival and growth. These proteins act downstream of receptor tyrosine kinases and are often associated with lipid kinase PI3K in signal transduction processes. The full activation of AKT kinases requires phosphorylation; p-AKT serves as a marker for activated AKT. The biological processes mediated by AKT include glycogen synthesis and glucose uptake influencing overall metabolic homeostasis.

Pathways

AKT kinases operate within critical pathways such as the PI3K/AKT/mTOR pathway and the insulin signaling pathway. These pathways regulate cellular metabolism proliferation and survival. AKT interacts with other proteins like mTOR and GSK3β integrating signals from growth factors and other external stimuli. By doing so AKT ensures proper cellular responses to external changes modulating processes like cell cycle entry.

AKT dysregulation associates with conditions like cancer and type 2 diabetes. In cancers AKT can become hyperactivated leading to unchecked cell growth and survival while in diabetes AKT function affects insulin signaling and glucose metabolism. AKT consequently interacts with proteins such as FOXO and BAD within these disease contexts influencing cell fate decisions and metabolic control. The AKT ELISA kit can be used to measure phosphorylated AKT levels offering insight into disease progression and treatment efficacy.

Product protocols

Target data

AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed : 11882383, PubMed : 15526160, PubMed : 15861136, PubMed : 21432781, PubMed : 21620960, PubMed : 31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960, PubMed : 29343641, PubMed : 31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed : 11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed : 11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed : 11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed : 12150915, PubMed : 12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed : 31548394, PubMed : 33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed : 10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed : 10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed : 10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed : 9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed : 9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed : 12176338, PubMed : 12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed : 19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its : kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed : 17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its : cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed : 20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed : 19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed : 10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed : 10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed : 23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed : 20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed : 18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed : 16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed : 16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed : 20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed : 32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors : forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed : 32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed : 30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed : 15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed : 31204173).
See full target information AKT1 phospho S473

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

Psychopharmacology : PubMed40526304

2025

Liraglutide improves depressive and cognitive deficits in a high-fat diet rat model of obesity: the role of hippocampal autophagy and the PI3K/Akt/mTOR pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yosra M Magdy,Sherif A Kamar,Mohamed Z Habib,Hagar Yousry Rady,Mohammed R Rabei,Sara Khedr

Drug delivery 32:2449376 PubMed39789884

2025

In vivo antitumor activity of PHT-427 inhibitor-loaded polymeric nanoparticles in head and neck squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Joaquín Yanes-Díaz,Raquel Palao-Suay,Francisca Inmaculada Camacho-Castañeda,Juan Riestra-Ayora,María Rosa Aguilar,Ricardo Sanz-Fernández,Carolina Sánchez-Rodríguez

Oncology letters 29:87 PubMed39677411

2024

Network pharmacology and molecular docking reveal the mechanism of action of Bergapten against non‑small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yihao Chen,Yu Fu,Hongbo Zou,Pingsong Wang,Yao Xu,Qichao Xie

Journal of biochemical and molecular toxicology 38:e70082 PubMed39651608

2024

Vitamin D3 Exerts a Neuroprotective Effect in Metabolic Syndrome Rats: Role of BDNF/TRKB/Akt/GS3Kβ Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Noha Aladdin,Salah A Ghareib

Journal of human reproductive sciences 17:185-192 PubMed39544683

2024

Utilisation of Oocyte Diameter as a Non-invasive Indicator of Oocyte and Embryo Quality: Investigating Protein Kinase B Protein Expression in Cumulus-Granulosa Cells and Embryo Morphokinetics.

Applications

Unspecified application

Species

Unspecified reactive species

Tita Yuningsih,Budi Wiweko,Arief Boediono,Ina Gunawati,Nining Handayani

Cancer letters 568:216286 PubMed37354984

2023

HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Alpha Raj Mekapogu,Zhihong Xu,Srinivasa Pothula,Chamini Perera,Tony Pang,S M Zahid Hosen,Vishnu Damalanka,James Janetka,David Goldstein,Romano Pirola,Jeremy Wilson,Minoti Apte

Antioxidants (Basel, Switzerland) 12: PubMed37238003

2023

Overexpression of Mitochondrial Catalase within Adipose Tissue Does Not Confer Systemic Metabolic Protection against Diet-Induced Obesity.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda J Croft,Conagh Kelly,Dongqing Chen,Tatt Jhong Haw,Aaron L Sverdlov,Doan T M Ngo

Aging 14:10125-10136 PubMed36575048

2022

Exosomes derived from human umbilical cord mesenchymal stem cells promote osteogenesis through the AKT signaling pathway in postmenopausal osteoporosis.

Applications

Unspecified application

Species

Unspecified reactive species

Shi-Wei Ren,Guang-Qing Cao,Qing-Run Zhu,Min-Gang He,Fang Wu,Su-Mei Kong,Zhao-Yan Zhang,Qiang Wang,Feng Wang

Evidence-based complementary and alternative medicine : eCAM 2022:5572869 PubMed35178106

2022

Therapeutic Effect of Catgut Implantation at Acupoint in a Mouse Model of Hepatocellular Carcinoma by Suppressing Immune Escape.

Applications

Unspecified application

Species

Unspecified reactive species

Shi-Hua Xu,Hao-Xuan Luo,Bi-Jun Huang,Ling Yu,Shao-Ju Luo,Hao Hu,Yan Li,Xiao-Tong Lin,Zhi-Rui Cao,Yuan-Jiang Deng,Shi-Jun Zhang

Frontiers in pharmacology 12:720173 PubMed35095479

2022

AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Eslam E Abd El-Fattah,Sameh Saber,Mahmoud E Youssef,Hanan Eissa,Eman El-Ahwany,Noha A Amin,Mohammed Alqarni,Gaber El-Saber Batiha,Ahmad J Obaidullah,Mohamed M Y Kaddah,Ahmed Gaafar Ahmed Gaafar,Ahmed A E Mourad,Gomaa Mostafa-Hedeab,Amir Mohamed Abdelhamid
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com